China May Soon Halt CBD Cosmetics Trade, Forcing Manufacturers To Turn To Exports | Benzinga via @benzinga
Back in March, Chinas National Institutes for Food and Drug Control revealed a proposed law that would forbid imports and cross-border e-commerce of hemp flowers, seed oil and extracts in cosmetics — the only CBD applications allowed for sale in the country.
“Cannabis cosmetics are undoubtedly one of the hottest products in China. Once the ban takes effect, it will have tremendous impact on the industry,” Hedy He, an analyst at the Hangzhou-based consultancy Chemlinked, reportedly told Cosmetics Design-Asia. “The rising prosperity in the cannabis cosmetic sector will come to a grinding halt.”
The idea behind the ban comes from anti-drug education initiatives that see the promotion of cannabis-infused cosmetic products as opposing the government principles set for the country’s younger population.
Furthermore, the government questions the availability of THC tests, which guarantee the THC amounts, and also says CBD can simply be replaced by other ingredients, according to Hemp Today.
If the law is enacted, many Chinese companies involved in CBD production will be forced to turn to export markets; according to some estimates, they already supply one-third of the world’s CBD.
Alan Brochstein’s 420 Investor is the go-to community for investors to learn, explore, and profit from the marijuana companies. The main goal of 420 Investor is to provide real-time, objective information about the top marijuana companies in the market in order to help investors capitalize on cannabis.
We’re an experienced team that is looking for a smart, driven, self-starter who has a high-level awareness to anticipate things that need to be done or comes up with new ideas to improve the product experience for our users.
Advertiser Disclosure: TD Ameritrade, Inc. and Accretive Capital LLC are separate, unaffiliated companies and are not responsible for each other’s services and products. Editorial Disclosure: Reviews are as determined by Benzinga Money. Opinions expressed here are solely the author’s and have not been reviewed, approved or otherwise endorsed by reviewers.